Try our beta test site
150 studies found for:    Open Studies | "Skin Diseases, Infectious"
Show Display Options
Rank Status Study
21 Recruiting The Effect of Dermatology and Teledermatology Consultations on Length of Hospital Admission, 30 Day Readmission Rate, and Antibiotic Use in Patients Presenting With Cellulitis vs Pseudocellulitis in an Academic Inpatient Setting
Condition: Cellulitis
Interventions: Other: teledermatology consult;   Other: Routine Care
22 Recruiting Study Assessing Impact of Dermatology Consultation for Patients Admitted With Cellulitis
Condition: Cellulitis
Intervention: Other: Dermatology consult
23 Recruiting Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo
Conditions: Erysipelas;   Impetigo;   Herpes Zoster;   Molluscum Contagiosum;   Warts;   Tinea;   Melanoma;   Actinic Keratosis;   Basal Cell Carcinoma;   Squamous Cell Carcinoma
Interventions: Procedure: Screening;   Device: Tele-dermatology
24 Recruiting Evaluation of Trichoscopy in the Diagnosis of Tinea Capitis
Condition: Tinea Capitis
Intervention: Device: Dermoscopy
25 Not yet recruiting Pharmacokinetics of IV Formulation
Condition: Invasive Aspergillosis
Intervention: Drug: F901318
26 Recruiting Influence of a Combined Pharmacogenetic Score on Through Plasma Voriconazole Concentrations in Haematological Patients
Conditions: Invasive Aspergillosis;   Haematological Cancer Patients;   Voriconazole
Intervention:
27 Recruiting Impact of Pre-existing Invasive Aspergillosis on Allogeneic Stem Cell Transplantation
Condition: Invasive Aspergillosis
Intervention:
28 Recruiting Novel Biomarkers for Invasive Aspergillosis
Condition: Aspergillosis Invasive
Intervention: Procedure: blood sample
29 Not yet recruiting Radiolabelled IV and Oral Metabolism Study of F901318
Condition: Invasive Aspergillosis
Interventions: Drug: IV F901318;   Drug: Oral F901318
30 Recruiting Multiple Ascending Oral Dose Study of F901318 in Healthy Subjects
Condition: Invasive Aspergillosis
Interventions: Drug: F901318 Dose level A oral;   Drug: Placebo dose level A oral;   Drug: F901318 Dose level B oral;   Drug: Placebo dose level B oral;   Drug: F901318 Dose level C oral;   Drug: Placebo Dose level C oral
31 Not yet recruiting A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of PC945
Condition: Aspergillosis
Interventions: Drug: PC945 - single doses;   Drug: Placebo - single doses;   Drug: PC945 - repeat doses;   Drug: Placebo - repeat doses
32 Recruiting Concentrations of Voriconazole in Blood and BAL-fluid After Inhalation and Oral Administration
Condition: Invasive Aspergillosis
Intervention: Drug: Voriconazole
33 Recruiting Exhaled Breath Analysis in the Early Detection of Aspergillosis
Condition: Invasive Aspergillosis
Intervention:
34 Recruiting A Study of VBP-245 in Pediatric Patients With Molluscum Contagiosum
Condition: Molluscum Contagiosum
Interventions: Drug: VBP-245 Topical Gel;   Drug: Vehicle
35 Not yet recruiting Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Adults
Condition: HSV Infection
Interventions: Drug: Pritelivir;   Drug: Foscarnet
36 Not yet recruiting Miltefosine and GM-CSF in Cutaneous Leishmaniasis
Condition: Cutaneous Leishmaniasis
Interventions: Drug: Sbv;   Drug: Miltefosine plus placebo;   Drug: Miltefosine plus GM-CSF
37 Not yet recruiting Predicting Visceral Leishmaniasis in HIV Infected Patients
Condition: Leishmaniasis, Visceral
Intervention: Other: No intervention
38 Recruiting Bio-equivalence Study Comparing Permethrin Cream, 5% With Elimite in Patients With Active Scabies.
Condition: Scabies
Interventions: Drug: Permethrin Cream, 5%;   Drug: Elimite
39 Recruiting A Study of a New Leishmania Vaccine Candidate ChAd63-KH
Condition: Leishmaniasis, Cutaneous
Intervention: Drug: ChAd63-KH
40 Not yet recruiting Efficacy Study Between Two Different Dosages of an Antiparasitic in Patients With Crusted Scabies
Conditions: Gale;   Severe Forms of Scabies;   Oral Parasitic Drug;   Ivermectin
Interventions: Drug: Ivermectin 200 µg/kg;   Drug: Ivermectin 400 µg/kg

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.